SOD1 and inflammatory bowel disease: This leads to an increase in colon length/body weight ratio, decreased spleen weight/body weight ratio, elevated SOD levels, and reduced MDA levels in serum and intestine, thereby highlighting its therapeutic potential for IBD (89).